Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label study of LSCD101 autologous limbal epithelial cell sheet transplantation for limbal stem cell deficiency
KCT0010067Phase 2Recruiting
- Sponsor
- CliPS BnC
- Start
- Jan 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of LSCD101 in limbal stem cell deficiency (LSCD), sponsored by CliPS BnC. Started Jan 2025; status: recruiting.
02
Drugs
LSCD101
03
Conditions
limbal stem cell deficiency (LSCD)
Beyond the preview
Go deeper on KCT0010067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010067.